New insights on interactions between HIV-1 and HSV-2

被引：13

作者：

Delany-Moretlwe S. ^{[1
]}

Lingappa J.R. ^{[1
]}

Celum C. ^{[1
]}

机构：

[1] Reproductive Health and HIV Research Unit, University of Witwatersrand, Hillbrow, Johannesburg 2038

来源：

Current Infectious Disease Reports | 2009年 / 11卷 / 2期

关键词：

Acyclovir;

D O I：

10.1007/s11908-009-0020-8

中图分类号：

学科分类号：

摘要：

Herpes simplex type 2 (HSV-2) infection is common and frequently asymptomatic. Concerns exist about the high prevalence of HSV-2, particularly in areas of high HIV prevalence, because of observations that HSV-2 is associated with an increased risk of HIV acquisition, transmission, and disease progression. Several randomized trials have tested or are testing whether HSV-2 treatment can limit the spread of HIV, with mixed results. Although treatment with acyclovir, 400 mg twice daily, does not reduce HIV incidence, suppressive acyclovir and valacyclovir reduce HIV levels in plasma and in the genital tract. Ongoing trials are evaluating whether HSV suppression will reduce HIV transmission and disease progression. Until a protective HSV-2 or HIV vaccine is available, effective interventions that reduce the effect of HSV-2 on HIV transmission are critically needed. © Current Medicine Group, LLC 2009.

引用

页码：135 / 142

页数：7

共 58 条

[1]

Looker K.J., Garnett G.P., Schmid G.P., An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection, Bull World Health Organ, 86, pp. 805-812, (2008)

[2]

Mbopi-Keou F.X., Gresenguet G., Mayaud P., Et al., Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: Opportunities for intervention, J Infect Dis, 182, pp. 1090-1096, (2000)

[3]

Safrin S., Ashley R., Houlihan C., Et al., Clinical and serologic features of herpes simplex virus infection in patients with AIDS, AIDS, 5, pp. 1107-1110, (1991)

[4]

Siegal F.P., Lopez C., Hammer G.S., Et al., Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions, N Engl J Med, 305, pp. 1439-1444, (1981)

[5]

Langenberg A., Benedetti J., Jenkins J., Et al., Development of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection, Ann Intern Med, 110, pp. 882-887, (1989)

[6]

Frenkel L.M., Garratty E.M., Shen J.P., Et al., Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes, Ann Intern Med, 118, pp. 414-418, (1993)

[7]

Celum C., Wald A., Hughes J., Et al., Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: A randomised, double-blind, placebo-controlled trial, Lancet, 371, pp. 2109-2119, (2008)

[8]

Wald A., Zeh J., Selke S., Et al., Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons, N Engl J Med, 342, pp. 844-850, (2000)

[9]

Kamali A., Nunn A.J., Mulder D.W., Et al., Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population, Sex Transm Infect, 75, pp. 98-102, (1999)

[10]

McFarland W., Gwanzura L., Bassett M.T., Et al., Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers, J Infect Dis, 180, pp. 1459-1465, (1999)

← 1 2 3 4 5 6 →